Novel application of paeoniflorin: Stabilization of atherosclerotic plaques via the AMPK/PPARδ signaling pathway
Vascular Pharmacology · 2026
DOI: 10.1016/j.vph.2026.107690 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vascular Pharmacology, 2026. Verfasst von Jiqian He und 5 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Key Laboratory of Glucolipid Metabolic Disorder, Ministry of…. Hauptthemen laut MEDLINE: Monoterpenes, Glucosides, Atherosclerosis, AMP-Activated Protein Kinases. Die Arbeit nennt 55 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Phenotypic switching of smooth muscle cells is a core event in atherosclerosis, and atherosclerosis is recognized as a smooth muscle cell-driven tumor-like disease. Paeoniflorin (PF), a bioactive monoterpene glycoside isolated from Paeonia lactiflora and Paeonia veitchii, which exerts beneficial effects on both cardiovascular diseases and tumors. However, whether it ameliorates atherosclerosis by mediating the phenotypic switching of VSMC to enhance plaque stability remains unclear. The present study aims to clarify the plaque-stabilizing efficacy of paeoniflorin and unravel its underlying mechanisms. METHODS: In vitro, tunicamycin induced VSMC to establish a phenotypic switching model. In vivo, ApoE-/- mice were fed a high-fat diet to induce atherosclerosis. Aortic tissue pathological changes were measured by Oil Red O staining, H&E staining, Sirius red staining, Masson staining, immunofluorescence, and fluorescence staining. Western blotting was employed for mechanistic studies. RESULTS: Our results indicated that PF significantly reduced GRP78 and vimentin expression in VSMC, while increased calponin expression. PF significantly improved cardiac function in ApoE-/- mice, reduced inflammatory factors, oxidative stress, plaque area and necrotic core regions, while increased plaque collagen content and fibrous cap thickness. Furthermore, PF downregulated the expression of aorta GRP78, CHOP, vimentin, osteopontin, KLF4, and MMP2, while upregulated α-SMA and calponin expression. Concurrently, PF activated the AMPK/PPARδ signaling pathway, inhibited GRP78 and vimentin expression, enhanced calponin expression, and improved atherosclerosis. CONCLUSIONS: This study demonstrated that PF inhibited ER stress-induced VSMC phenotypic switching by activated the AMPK/PPARδ signaling pathway, thus enhanced atherosclerosis plaque stability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China, China; Institute of Chinese Medicine, Guangdong P…
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
He, J., Liu, J., Zheng, Z., Fan, F., Luo, Z., & Luo, D. (2026). Novel application of paeoniflorin: Stabilization of atherosclerotic plaques via the AMPK/PPARδ signaling pathway. Vascular Pharmacology. https://doi.org/10.1016/j.vph.2026.107690
Vancouver
He J, Liu J, Zheng Z, Fan F, Luo Z, Luo D. Novel application of paeoniflorin: Stabilization of atherosclerotic plaques via the AMPK/PPARδ signaling pathway. Vascular Pharmacology. 2026. doi:10.1016/j.vph.2026.107690
BibTeX
@article{He2026,
author = {He, Jiqian and Liu, Jiali and Zheng, Zhensen and Fan, Faxin and Luo, Zhizhong and Luo, Duosheng},
title = {Novel application of paeoniflorin: Stabilization of atherosclerotic plaques via the AMPK/PPARδ signaling pathway},
journal = {Vascular Pharmacology},
year = {2026},
doi = {10.1016/j.vph.2026.107690}
}
EUVIMED